Publications HAL



644 documents

  • Naveh Raz, Glen Pridham, Michael Rera, Uri Alon. Dynamics of the end-of-life phase explained by the saturating removal model. 2026. ⟨hal-05604914⟩
  • Marina Abakarova, Maria Inés Freiberger, Arnaud Liehrmann, Michael Rera, Elodie Laine. Proteome-wide prediction of the functional impact of missense variants with ProteoCast. Nature Communications, 2026, 17 (1), pp.3813. ⟨10.1038/s41467-026-72140-1⟩. ⟨hal-05604916⟩
  • Justine Bruse, Clothilde Marbach, Arnaud Polizzi, Tatiana Landré, Juliette Salvi, et al.. Hepatic FGF21 is not required for fasting metabolism but guides protein appetite post energy depletion. EMBO Reports, 2026, Online ahead of print. ⟨10.1038/s44319-026-00790-9⟩. ⟨hal-05610553⟩
  • Luce Breuil, Marie Doumic, Sarah Kaakaï, Michaël Rera. Acute Smurf mortality and age-dependence in a two-phase ageing model.. 2026. ⟨hal-05589412⟩
  • Michael Rera. On intestinal barrier dysfunction as a conserved late-life state in ageing. 2026. ⟨hal-05535422⟩
  • Daniel Nussey, Fabrizio D’adda Di Fagagna, Allison Bardin, Helen Blau, Anne Brunet, et al.. Molecular evolution of animal aging. The EMBO Journal, 2026, 45 (7), pp.2095-2111. ⟨10.1038/s44318-026-00725-z⟩. ⟨hal-05583999⟩
  • Bryon Silva, Mael Lemoine, Michael Rera, Dafni Hadjieconomou. The Enterarchon: An ancient visceral brain. Current Opinion in Neurobiology, 2026, 96, pp.103162. ⟨10.1016/j.conb.2025.103162⟩. ⟨hal-05608210⟩
  • M. Boulée, V. Bard, M. Papin, D. Béal, S. Devineau, et al.. Toxicity of polycaprolactone nanoplastics, pristine or weathered in environmental conditions, to human intestinal epithelial cells, in vitro. NanoImpact, 2026, 42, pp.100619. ⟨10.1016/j.impact.2026.100619⟩. ⟨hal-05546242⟩
  • Chloé Amouyal, Shiou Ping Chen, Jessica Denom, Ilyès Raho, Nadim Kassis, et al.. Serine palmitoyltransferase-mediated de novo sphingolipid biosynthesis is required for normal insulin production and glucose tolerance. 2025. ⟨hal-05419478⟩
  • Julien Chilloux, Francois Brial, Amandine Everard, David Smyth, Petros Andrikopoulos, et al.. Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control. Nature Metabolism, 2025, 7 (12), pp.2531-2547. ⟨10.1038/s42255-025-01413-8⟩. ⟨hal-05408577⟩